Open innovation

Our open innovation strategy is designed to promote change beyond GSK by sharing expertise, resources, intellectual property and know-how with external researchers and the scientific community.

Our previous focus was on diseases of the developing world, such as malaria, tuberculosis and parasitic infections and, we are now adapting open innovation models to apply to other areas of great medical need and scientific challenge including infectious, autoimmune disease, immuno-oncology and rare diseases.

Our 30-year quest to develop a malaria vaccine

We’ve been fighting malaria on all fronts for the past 100 years - and are now on the verge of developing the first malaria vaccine - as well as signing a five-year partnership with Comic Relief to provide on-the-ground support in some of the worst affected areas.